NCT03320616View on ClinicalTrials.gov

EYP001a Food Effect Study in Subjects With Chronic Hepatitis B Virus (HBV) Infection

PHASE1CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

October 12, 2017

Study Completion Date

October 12, 2017

Conditions

Hepatitis B, Chronic

Interventions

DRUG

EYP001a

Oral EYP001a capsules - 100 mg strength

Trial Locations (1)

Unknown

PRA-EDS, Groningen

Sponsors

Lead Sponsor

Collaborators (1)

PRA Health Sciences

All Listed Sponsors

collaborator

PRA Health Sciences

INDUSTRY

lead

Enyo Pharma

INDUSTRY